Sign In
Buy BNTX
$88.45
-0.690 (-0.774%)
At Close: Jun 03, 2026
The 3 Best Bargain Stocks to Buy in Q2 2024
03:39pm, Sunday, 31'st Mar 2024
Best bargain stocks to buy is a simple but tricky concept. Whenever shares trade lower than an established multiple, whether that by earnings, sales, book or some other metric, there might be a reason
3 Biotech Stocks to Buy for the Next Bull Run: March 2024
06:44am, Tuesday, 26'th Mar 2024
As we step into March 2024, the spotlight is turning towards the biotech sector, with investors searching for biotech stocks to buy. Biotech stocks are ready to soar after a period of under-performanc
BioNTech gets US agency notice over default on COVID vaccine royalties
07:28am, Monday, 25'th Mar 2024
BioNTech said on Monday the U.S. National Institutes of Health has sent a notice to the German company regarding default on the payment of royalties and other amounts related to its COVID-19 vaccine.
BioNTech's Brew: Mixing COVID Legacy With Oncology Ambitions
02:43pm, Wednesday, 20'th Mar 2024
BioNTech's Q4 earnings shows a significant revenue drop and profitability concerns, with expectations of continued vaccine demand decline. Despite short-term challenges, BioNTech's mRNA technology and
BioNTech SE (BNTX) Q4 2023 Earnings Call Transcript
01:30pm, Wednesday, 20'th Mar 2024
BioNTech SE (BNTX) Q4 2023 Earnings Call Transcript
BioNTech Earnings Fall Short of Estimates. The Stock Is Down.
07:44am, Wednesday, 20'th Mar 2024
The pharmaceutical firm has been hit hard as demand for Covid-19 vaccines plunged.
BioNTech Q4 earnings: COVID franchise to remain a notable cash contributor in 2024
07:33am, Wednesday, 20'th Mar 2024
BioNTech SE (NASDAQ: BNTX) is down nearly 5.0% in premarket on Wednesday after reporting disappointing financial results for the fourth quarter. BioNTech stock down on muted guidance The stock is bein
BioNTech's stock sinks after earnings fall below expectations, hurt by writedowns of vaccine inventory
06:27am, Wednesday, 20'th Mar 2024
Shares of BioNTech SE BNTX, +1.22% dropped 4.4% in premarket trading Wednesday, after the Germany-based biotechnology company reported fourth-quarter results that fell sharply to miss expectations, we
After earnings plunge, BioNTech pins hopes on cancer drug launches
06:18am, Wednesday, 20'th Mar 2024
Germany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, reported on Wednesday a plunge in 2023 revenue and earnings as its focus shifts towards canc
This Biotech Stock Plunged 20% but Wall Street Expects a 195% Recovery
09:15am, Friday, 15'th Mar 2024
Investing in biopharmaceutical stocks comes with more risks than some other types of stocks.
BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
07:45am, Monday, 11'th Mar 2024
MAINZ, Germany, March 11, 2024 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data for selected candidates from its oncology pipeline at the American A
3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success
04:45pm, Wednesday, 06'th Mar 2024
Biotech stocks have always been high-risk and high-reward, with the futures and fortunes of companies often decided with a single successful drug trial or Federal Drug Administration (FDA) approval. T
BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024
06:45am, Wednesday, 06'th Mar 2024
MAINZ, Germany, March 6, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the full year and fourth quarter 2023 on Wedne
Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound
06:42pm, Monday, 04'th Mar 2024
Ordinarily, you'll want to avoid excessively red-stained ideas. Although certain exceptions might be made for these oversold stocks ready for rebound.
It's Time! 3 Dodgy Pharma Stocks to Sell in February
10:06am, Monday, 04'th Mar 2024
Much like Big Tech companies ride the AI hype, pharma stocks are counting on valuation boosts from big drug hits and FDA approvals. This anticipation, however, brings to light the importance of discer
